Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212

被引:11
作者
Katsumata, Kenji [1 ]
Enomoto, Masanobu [1 ]
Ishizaki, Tetsuo [1 ]
Fujita, Shin [2 ]
Kanemitsu, Yukihide [3 ]
Ito, Masaaki [4 ]
Shiomi, Akio [5 ]
Komori, Koji [6 ]
Ohue, Masayuki [7 ]
Ota, Mitsuyoshi [8 ]
Akazai, Yoshihiro [9 ]
Shiozawa, Manabu [10 ]
Yamaguchi, Takashi [11 ]
Bando, Hiroyuki [12 ]
Sekimoto, Mitugu [13 ,14 ]
Kobatake, Takaya [15 ]
Machida, Ryunosuke [16 ]
Akasu, Takayuki [17 ]
Moriya, Yoshihiro [18 ]
机构
[1] Tokyo Med Univ, Dept Gastrointestinal & Pediat Surg, Shinjyuku Ku, 6-7-1 Nishi Shinjyuku, Tokyo 1600023, Japan
[2] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan
[3] Natl Canc Ctr, Dept Colorectal Surg, Tokyo, Japan
[4] Natl Canc Ctr Hosp East, Dept Colorectal Surg, Chiba, Japan
[5] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[6] Aichi Canc Ctr Hosp, Dept Surg, Nagoya, Aichi, Japan
[7] Osaka Int Canc Inst, Dept Gastroenterol Surg, Osaka, Japan
[8] Yokohama City Univ, Med Ctr, Dept Surg, Yokohama, Kanagawa, Japan
[9] Okayama Saiseikai Gen Hosp, Dept Surg, Okayama, Japan
[10] Kanagawa Canc Ctr, Dept Surg, Yokohama, Kanagawa, Japan
[11] Kyoto Med Ctr, Dept Surg, Kyoto, Japan
[12] Ishikawa Prefectural Cent Hosp, Dept Surg, Kanazawa, Ishikawa, Japan
[13] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan
[14] Shikoku Canc Ctr, Dept Surg, Matsuyama, Ehime, Japan
[15] Natl Canc Ctr, JCOG Data Ctr, Tokyo, Japan
[16] Natl Canc Ctr, Operat Off, Tokyo, Japan
[17] Imperial Household Agcy Hosp, Dept Surg, Tokyo, Japan
[18] Japanese Red Cross Med Ctr, Dept Surg, Tokyo, Japan
关键词
Rectal cancer; Latera lymph node dissection; Surgical site infection; Recurrence; DISSECTION; RECURRENCE; RESECTION; SURGERY;
D O I
10.1007/s10585-021-10117-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to examine the risk factors for surgical site infection (SSI) and the association of that with recurrence in JCOG0212. The results for secondary endpoints showed that compared with the mesorectal excision (ME) alone group, ME with lateral lymph node dissection (LLND) group showed significantly longer operative time and significantly higher blood loss. These results suggested that LLND was a risk factor for SSI. All 701 patients registered in JCOG0212 were analyzed in this study. Wound infection was defined as incisional/deep SSI, and pelvic abscess and anastomotic leakage were defined as organ/space SSI. The risk factors for the incidence of SSI and the effect of SSI on relapse-free survival (RFS) were investigated. Multivariable odds ratio of Grade 2 or higher all SSI was 0.58 [95% Confidence interval: 0.36-0.93] for female (vs. male) and that of Grade 2 or higher incisional/deep SSI was 2.24 [1.03-4.86] for blood infusion. For RFS, patients with Grade 3 or higher all SSI showed poor prognosis (multivariable hazard ratio: 1.66 [1.03-2.68]). LLND is not significant factor for the incidence of all SSI. Male sex might be a risk factor of Grade 2 or higher SSI, and blood transfusion is a possible risk factor of Grade 2 or higher incisional/deep SSI. Grade 3 or higher all SSI might be a significant worse prognostic factor for lower rectal cancer.
引用
收藏
页码:459 / 466
页数:8
相关论文
共 18 条
  • [1] Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis
    Allegranzi, Benedetta
    Nejad, Sepideh Bagheri
    Combescure, Christophe
    Graafmans, Wilco
    Attar, Homo
    Donaldson, Liam
    Pittet, Didier
    [J]. LANCET, 2011, 377 (9761) : 228 - 241
  • [2] [Anonymous], 2017, Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
  • [3] [Anonymous], 1999, NAT CANC I COMM TOX
  • [4] FUJITA S, 1993, JPN J CLIN ONCOL, V23, P299
  • [5] Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212) A Multicenter, Randomized Controlled, Noninferiority Trial
    Fujita, Shin
    Mizusawa, Junki
    Kanemitsu, Yukihide
    Ito, Masaaki
    Kinugasa, Yusuke
    Komori, Koji
    Ohue, Masayuki
    Ota, Mitsuyoshi
    Akazai, Yoshihiro
    Shiozawa, Manabu
    Yamaguchi, Takashi
    Bandou, Hiroyuki
    Katsumata, Kenji
    Murata, Kohei
    Akagi, Yoshihito
    Takiguchi, Nobuhiro
    Saida, Yoshihisa
    Nakamura, Kenichi
    Fukuda, Haruhiko
    Akasu, Takayuki
    Moriya, Yoshihiro
    [J]. ANNALS OF SURGERY, 2017, 266 (02) : 201 - 207
  • [6] Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial
    Fujita, Shin
    Akasu, Takayuki
    Mizusawa, Junki
    Saito, Norio
    Kinugasa, Yusuke
    Kanemitsu, Yukihide
    Ohue, Masayuki
    Fujii, Shoichi
    Shiozawa, Manabu
    Yamaguchi, Takashi
    Moriya, Yoshihiro
    [J]. LANCET ONCOLOGY, 2012, 13 (06) : 616 - 621
  • [7] Parallel-group controlled trial of esophagectomy versus chemoradiotherapy in patients with clinical stage I esophageal carcinoma (JCOG0502).
    Kato, Ken
    Igaki, Hiroyasu
    Ito, Yoshinori
    Nozaki, Isao
    Daiko, Hiroyuki
    Yano, Masahiko
    Ueno, Masaki
    Nakagawa, Satoru
    Takagi, Masakazu
    Tsunoda, Shigeru
    Abe, Tetsuya
    Nakamura, Tetsu
    Hihara, Jun
    Toh, Yasushi
    Shibuya, Yuichi
    Mizusawa, Junki
    Katayama, Hiroshi
    Nakamura, Kenichi
    Kitagawa, Yuko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] Kobayashi M, 2009, J Jpn Soc Surg Infect, V6, P587
  • [9] Anastomotic Leak Increases Distant Recurrence and Long-Term Mortality After Curative Resection for Colonic Cancer
    Krarup, Peter-Martin
    Nordholm-Carstensen, Andreas
    Jorgensen, Lars N.
    Harling, Henrik
    [J]. ANNALS OF SURGERY, 2014, 259 (05) : 930 - 938
  • [10] The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer
    Li, Zhigui
    Zhao, Rui
    Cui, Yaping
    Zhou, Yong
    Wu, Xiaoting
    [J]. SCIENTIFIC REPORTS, 2018, 8